- Refractory Crohn's disease2014 | First Faculty of Medicine
- Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?2023 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine, Third Faculty of Medicine
- Subcutaneous infliximab in the treatment of refractory Crohn‘s disease patients – a pilot study of drug immunogenicity2023 | First Faculty of Medicine